Therapeutic Strategies for Systemic Necrotizing Vasculitides

Treatments of vasculitides have progressed markedly over the past few decades. The first attempts to obtain better-adapted therapeutic strategies evaluated the indications of conventional drugs, and their abilities prolong survival and reduce the number of relapses, while decreasing the severity and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Allergology International 2007, Vol.56 (2), p.105-111
Hauptverfasser:	Guillevin, Loïc, Pagnoux, Christian
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones - therapeutic use ANCA Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived Antigens, CD20 - immunology Antiviral Agents - therapeutic use Blood Vessels - pathology Churg-Strauss Syndrome - immunology Churg-Strauss Syndrome - therapy Cyclophosphamide - therapeutic use Etanercept Granulomatosis with Polyangiitis - immunology Granulomatosis with Polyangiitis - therapy Hepatitis B - complications Hepatitis C - complications HIV Infections - complications Humans Immunoglobulin G - therapeutic use Immunoglobulins, Intravenous - therapeutic use Immunologic Factors - therapeutic use immunosuppressants Immunosuppressive Agents - therapeutic use Infliximab Necrosis Plasma Exchange polyarteritis nodosa Polyarteritis Nodosa - immunology Polyarteritis Nodosa - therapy Receptors, Tumor Necrosis Factor - therapeutic use Rituximab Treatment Outcome Tumor Necrosis Factor-alpha - immunology vasculitis Vasculitis - drug therapy Vasculitis - immunology Vasculitis - pathology Vasculitis - therapy Vasculitis - virology Wegener's granulomatosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!